Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Gross Margin (2022 - 2025)

Envoy Medical's Gross Margin history spans 4 years, with the latest figure at 181.33% for Q4 2025.

  • Quarterly results put Gross Margin at 181.33% for Q4 2025, down 140990.0% from a year ago — trailing twelve months through Dec 2025 was 401.24% (down 24791.0% YoY), and the annual figure for FY2025 was 262.66%, down 3288.0%.
  • Gross Margin for Q4 2025 was 181.33% at Envoy Medical, up from 864.29% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 1228.57% in Q4 2024 to a low of 864.29% in Q3 2025.
  • The 4-year median for Gross Margin is 190.67% (2025), against an average of 260.39%.
  • The sharpest move saw Gross Margin soared 137489bps in 2024, then tumbled -140990bps in 2025.
  • Year by year, Gross Margin stood at 655.0% in 2022, then skyrocketed by 78bps to 146.32% in 2023, then surged by 940bps to 1228.57% in 2024, then tumbled by -115bps to 181.33% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 181.33%, 864.29%, and 200.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.